Concepedia

Tianqi Chen

TC

28

Publications

1.3K

Citations

20

H-Index

2015

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Massachusetts General Hospital

Harvard University

Chinese Academy of Medical Sciences & Peking Union Medical College

Brigham and Women's Hospital

Tianqi Chen is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2015–2024

28

Publications

28

A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant‐ineligible multiple myeloma

Elizabeth O’Donnell, Jacob P. Laubach, Andrew J. Yee et al. · British Journal of Haematology · 2018 · 156 citations · Full text

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer

David T. Miyamoto, Richard J. Lee, Mark Kalinich et al. · Cancer Discovery · 2018 · 133 citations · Full text

Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy

Xin Hong, Ryan J. Sullivan, Mark Kalinich et al. · Proceedings of the National Academy of Sciences · 2018 · 127 citations · Full text

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma

Gabriel J. Starrett, Manisha Thakuria, Tianqi Chen et al. · Genome Medicine · 2020 · 115 citations · Full text

The oncomicropeptide APPLE promotes hematopoietic malignancy by enhancing translation initiation

Lin-Yu Sun, Wentao Wang, Cai Han et al. · Molecular Cell · 2021 · 110 citations

, , +7

Rows per page

1–5 of 28